£113.03

About as cheap as it gets — within 5% of the all-time low it hit 2 months ago.

£113 today · all-time low £111 (Sep 2026) · usually £114

Springer Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 74 days · 74 data points (no recent data)

Historical
Generating forecast…
£114.71 £110.37 £111.31 £112.26 £113.21 £114.16 £115.10 11 August 2026 29 August 2026 16 September 2026 04 October 2026 23 October 2026
View at Amazon ↗

Price data last checked 17 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 74 days • 4 price levels

Days at Price
Current Price
29 days 6 days · current 12 days 27 days 0 7 15 22 29 £111 £113 £114 £115 Days at Price

Price Analysis

Most common price: £111 (29 days, 39.2%)

Price range: £111 - £115

Price levels: 4 different prices over 74 days

Description

This book will compile a collection of chapters dedicated to varied aspects of PPPM in neuropsychiatric and neurodegenerative diseases. Among the topics to be covered are: Recent advances in ALS research News about Clinical aspects and advanced therapy approaches in personalized treatment of ALS Schizophrenia: New treatments and clinical aspects Predictive, Preventive and Personalised Medicine in aging macular degeneration Advances in Multiple Sclerosis Pharmacogenetics, Tailoring Treatment Efficacy, Safety and Regimen Selection Multiple sclerosis related biomarkers: perspectives for clinical application Preventive clinical trials in brain aging: new trends & the need of guidelines MCI_ clinical guidelines in early diagnosis of dementia Alzheimer's disease: diagnostics, prognostics and the road to prevention Biomarkers for early diagnosis of Parkinson's and Alzheimer's diseases Synucleinopathies, tauopathies, TDP-43 proteinopathies and amyloidosis PSP, MSA and other parkinsonisms

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
08 February 2015
Listed Since
05 February 2015

Barcode

No barcode data available

Similar Products You Might Like

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
97% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£107.23 04 Nov 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
87% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£97.49 17 Oct 2026
Neurodegenerative Disorders: A Clinical Guide
86% match

Neurodegenerative Disorders: A Clinical Guide

Springer

£60.42 23 Oct 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
84% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£147.14 22 Oct 2026
Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)
84% match

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Springer

£108.15 30 Oct 2026
Rare Diseases: Integrative PPPM Approach as the Medicine of the Future: 6 (Advances in Predictive, Preventive and Personalised Medicine, 6)
84% match

Rare Diseases: Integrative PPPM Approach as the Medicine of the Future: 6 (Advances in Predictive, Preventive and Personalised Medicine, 6)

Springer

£76.42 23 Oct 2026
Molecular Imaging of Neurodegenerative Disorders
84% match

Molecular Imaging of Neurodegenerative Disorders

Springer

£96.81 26 Oct 2026
Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)
83% match

Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)

Springer

£71.18 27 Oct 2026
83% match

Epigenetics and miRNA in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Elsevier

£157.99 21 Oct 2026
Neurodegenerative Disorders: Loss of Function Through Gain of Function (Research and Perspectives in Alzheimer's Disease)
82% match

Neurodegenerative Disorders: Loss of Function Through Gain of Function (Research and Perspectives in Alzheimer's Disease)

Springer

£108.45 30 Oct 2026
The Benefits of Natural Products for Neurodegenerative Diseases: 12 (Advances in Neurobiology, 12)
82% match

The Benefits of Natural Products for Neurodegenerative Diseases: 12 (Advances in Neurobiology, 12)

Springer

£113.67 22 Oct 2026
82% match

Building Blocks of Neuroimmunometabolism: From Molecular Pathways to Therapeutic Strategies

Elsevier

£157.99 21 Oct 2026
Advanced and Integrative Therapeutic Strategies in Parkinson’s Disease Management
82% match

Advanced and Integrative Therapeutic Strategies in Parkinson’s Disease Management

Elsevier

£133.99 22 Oct 2026
Alzheimer’s Disease: A Physician’s Guide to Practical Management (Current Clinical Neurology)
82% match

Alzheimer’s Disease: A Physician’s Guide to Practical Management (Current Clinical Neurology)

Humana

£74.21 23 Oct 2026
Neurodegenerative Diseases: 6 (Topics in Medicinal Chemistry, 6)
81% match

Neurodegenerative Diseases: 6 (Topics in Medicinal Chemistry, 6)

Springer

£108.06 23 Oct 2026
Neuroprotection Methods and Protocols: 399 (Methods in Molecular Biology, 399)
81% match

Neuroprotection Methods and Protocols: 399 (Methods in Molecular Biology, 399)

Humana

£76.06 25 Oct 2026
Neuro-Immune Interactions in Neurologic and Psychiatric Disorders (Research and Perspectives in Neurosciences)
81% match

Neuro-Immune Interactions in Neurologic and Psychiatric Disorders (Research and Perspectives in Neurosciences)

Springer

£73.85 29 Oct 2026
Neuropsychiatric Disorders
81% match

Neuropsychiatric Disorders

Springer

£113.77 23 Oct 2026
Advances in Genomics and Neurosciences for Neurologic and Behavioral Disorders
81% match

Advances in Genomics and Neurosciences for Neurologic and Behavioral Disorders

Elsevier

£145.99 22 Oct 2026
Medical Neuropsychology: Second Edition (Critical Issues in Neuropsychology)
81% match

Medical Neuropsychology: Second Edition (Critical Issues in Neuropsychology)

Springer

£111.36 20 Oct 2026
Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)
81% match

Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)

Humana

£62.45 21 Oct 2026
Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)
81% match

Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)

Springer

£108.97 22 Oct 2026
Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)
81% match

Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)

Springer

£144.94 22 Oct 2026
Neuropalliative Care: A Guide to Improving the Lives of Patients and Families Affected by Neurologic Disease
81% match

Neuropalliative Care: A Guide to Improving the Lives of Patients and Families Affected by Neurologic Disease

Springer

£89.52 29 Oct 2026